Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

ISFAHAN UNIVERSITY OF MEDICAL SCIENCES

🇮🇷Iran

Country: 🇮🇷Iran

Ownership: Private

Established: 1024-01-01

Employees: -

Market Cap: -

Website: http://www.mui.ac.ir

Clinical Trials

Comparison of Three Methods for NG Tube Placement

Not Applicable

Completed

Conditions: Unconsciousness

Interventions: Procedure: NG tube insertion method

First Posted Date: 2018-10-09

Last Posted Date: 2018-10-09

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 75

Registration Number: NCT03699306

Locations: 🇮🇷
Al-Zahra University Hospital, Isfahan, Iran, Islamic Republic of
🇮🇷
Mehdi Nasr Isfahani, Isfahan, Iran, Islamic Republic of

Effect of Tetracycline Pleurodesis on Prevention of Primary Spontaneous Pneumothorax Recurrence

Not Applicable

Completed

Conditions: Primary Spontaneous Pneumothorax

Interventions: Procedure: Chemical pleurodesis
Drug: Tetracycline Topical Ointment
Drug: Lidocaine 2% Injectable Solution
Drug: Normal saline

First Posted Date: 2018-08-16

Last Posted Date: 2018-08-21

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 50

Registration Number: NCT03634605

Locations: 🇮🇷
Isfahan Unviersity of medical Sciences, Isfahan, Iran, Islamic Republic of

A Polypill for Secondary Prevention of Ischemic Heart Disease

Phase 3

Conditions: Non-ST Elevation Myocardial Infarction
Acute Myocardial Infarction
ST Elevation Myocardial Infarction

Interventions: Drug: Polypill

First Posted Date: 2018-05-30

Last Posted Date: 2020-10-14

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 1200

Registration Number: NCT03541109

Locations: 🇮🇷
Chamran cardiology hospital, Isfahan, Iran, Islamic Republic of
🇮🇷
Cardiovascular Research Institute, Isfahan, Iran, Islamic Republic of

Effect of Lidocaine/Dexamethasone on the Success of IANB

Phase 2

Completed

Conditions: Local Anesthesia

Interventions: Drug: Dexamethasone
Drug: Placebo

First Posted Date: 2018-05-22

Last Posted Date: 2018-05-22

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 100

Registration Number: NCT03531970

Locations: 🇮🇷
Isfahan University of Medical Sciences, Isfahan, Iran, Islamic Republic of

Low-Dose Intravenous Ketamine Bolus Versus Conventional Technique

Phase 2

Conditions: Procedural Sedation

Interventions: Drug: Ketamine Hcl 50Mg/Ml Inj
Drug: Ketamine Hydrochloride 50Mg/1mL Solution for Injection

First Posted Date: 2018-04-17

Last Posted Date: 2018-04-17

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 198

Registration Number: NCT03499886

Locations: 🇮🇷
Al-Zahra University Hospital, Isfahan, Iran, Islamic Republic of
🇮🇷
Mehdi Nasr Isfahani, Isfahan, Iran, Islamic Republic of

The Effectiveness of Vancomycin in Comarison With Cefazolin in Prevention of SSI After Craniotomy

Phase 1

Conditions: Elective Craniotomy-candidated Patients

Interventions: Drug: Vancomycin
Drug: Cefazolin

First Posted Date: 2018-03-15

Last Posted Date: 2018-03-15

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 126

Registration Number: NCT03466645

Locations: 🇮🇷
Isfahan university of medical science., Isfahan, Iran, Islamic Republic of

Buspirone Plus Omeprazole for Functional Dyspepsia

Phase 4

Completed

Conditions: Dyspepsia

Interventions: Drug: Placebo Oral Tablet
Drug: Buspirone

First Posted Date: 2018-02-23

Last Posted Date: 2018-02-23

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 70

Registration Number: NCT03444831

Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction

Phase 2

Conditions: Non-ST Elevation Myocardial Infarction (nSTEMI)
Vitamin D Deficiency
Inflammation
Coronary Artery Disease With Myocardial Infarction

Interventions: Drug: Vitamin D3 50000 UNT Oral Capsule
Drug: Placebo oral capsule

First Posted Date: 2018-01-23

Last Posted Date: 2018-08-20

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 70

Registration Number: NCT03405207

Locations: 🇮🇷
Cardiovascular Rehabilitation Research Center, Isfahan, Iran, Islamic Republic of

Allogenic Mesenchymal Stem Cell Derived Exosome in Patients With Acute Ischemic Stroke

Phase 1

Conditions: Cerebrovascular Disorders

Interventions: Biological: exosome

First Posted Date: 2017-12-27

Last Posted Date: 2021-01-25

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 5

Registration Number: NCT03384433

Locations: 🇮🇷
Shahid Beheshti University of Medical Sciences, Tehran, Iran, Islamic Republic of

Bier's Block Versus Systemic Analgesia

Phase 2

Conditions: Distal Radius Fracture

Interventions: Procedure: Intravenous Regional Anesthesia
Drug: Systemic Analgesia

First Posted Date: 2017-11-21

Last Posted Date: 2017-11-21

Lead Sponsor: Isfahan University of Medical Sciences

Target Recruit Count: 70

Registration Number: NCT03349216

Locations: 🇮🇷
Al-Zahra Hospital, Isfahan, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy